Casandra
Casandra Test Code QD15259Version 1 (DRAFT)
Performing Lab
COLONSEQPlus Panel
Clinical Use
Order TestUse
This disease‑specific solid tumor panel is intended to aid the oncologist in prioritizing standard‑of‑care therapy choices for patients with colorectal cancer.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
NGS (Targeted)
Biomarkers
Mutation (13 genes)
APCBRAFCTNNB1EGFRERBB2FBXW7KRASMETNRASPIK3CAPTENSMAD4TP53
Result Turnaround Time
8-10 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
Paraffin‑embedded tissue in sterile biohazard bag OR 15 FFPE slides and H&E slide (or 1 additional slide) in slide holder
Collection Instructions
Paraffin‑embedded tissue accompanied by a circled H&E slide indicating area OR 15 FFPE slides and H&E (or additional) collected in slide holder
Causes for Rejection
Decalcified tissue specimen
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinitely |
| Refrigerated | Indefinitely |
| Frozen | Unacceptable |
Related Tests
Other tests from different labs that may be relevant
NeoTYPE® Colorectal Tumor Profile
NeoGenomics
MayoComplete Colorectal Cancer Panel, Next-Generation Sequencing, Tumor
Mayo Clinic Lab
oncoReveal™ CDx
MPLN
BRAF V600 Mutation Analysis
MPLN
Hereditary Colorectal Cancer and Polyposis Panel
Prevention Genetics
KRAS Mutation Analysis (Extended) in Colorectal Cancer (CRC)
Labcorp
KRAS Gene Mutation Analysis, IVD
Labcorp